Beards: Gas-Mask Obstruction, Camouflage, and Cultural Icon
JACKSONVILLE, Fla., Nov. 30, 2017 /PRNewswire-USNewswire/ -- The month of November draws to a close, and razor companies everywhere are breathing easier again as legions of men resume trimming their facial hair. If you spent the last month scratching the unfamiliar fur on your face, congratulations, you made it through No-shave November. The month-long tradition has roots in supporting worthy causes and raising awareness by growing a beard. For others, it's a way to justify not shaving for an entire month due to laziness. For others still, it's a test of manly prowess to see who among a group of friends can grow the biggest beard in a month.
Often, regardless of motivation or reason, the beard gets trimmed or shaven off entirely at the end of the month.
However, for some service members like those in the Special Forces, every day is No-shave November. At Wounded Warrior Project® (WWP), we recognize while the act of shaving relates to personal grooming and discipline, in some situations, the presence of a beard can mean the difference between life and death.
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...
Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treatment and prevention of bleeds and perioperative...
Citius Pharmaceuticals Inc. ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive...
Florida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio N. Gordan, MD will serve as a panelist at the 2024 Oncology Fellows & Faculty Forum in Miami, sponsored by PrecisCa and the Community Oncology Alliance...
Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio, renal and metabolic diseases, today announced its participation at two prestigious medical conferences: the American...
